Insights

Recruitment Growth Antidote specializes in matching patients with clinical studies, and its partnership with Seqster aims to combine precision recruitment with real time participant health data. This creates a strong opportunity for vendors offering patient engagement, data integration, analytics, or recruitment optimization solutions.

Partner Expansion Collaborations with MSAA, Beyond Type 1, JDRF, and Beyond Celiac show a strategy of reaching patients through advocacy organizations and condition specific journeys. Business development teams can explore partnerships, outreach platforms, and content or engagement services that help scale these programs.

Trust Readiness Antidote earned a second consecutive EcoVadis Silver rating and completed a CyberGRX security assessment with strong results. Its focus on sustainability and cybersecurity may create demand for compliance support, privacy tooling, security services, and responsible supply chain solutions.

Lean Technology With 11 to 50 employees, Antidote runs a cloud based technology stack including Google Cloud, Kubernetes, PostgreSQL, Salesforce, and Elasticsearch. This lean operating model may make scalable cloud infrastructure, automation, systems integration, and managed services relevant sales propositions.

Focused Scale Antidote reports $52 million in funding and estimated revenue of $1 million to $10 million, positioning it as a funded specialist competing in a market with much larger research services and technology providers. Sales outreach should emphasize measurable recruitment outcomes, efficient deployment, and solutions that support growth without adding substantial operational burden.

Similar companies to Antidote Technologies

Antidote Technologies Tech Stack

Antidote Technologies uses 8 technology products and services including Kubernetes, OneTrust, Salesforce, and more. Explore Antidote Technologies's tech stack below.

Media & News

Antidote Technologies's Email Address Formats

Antidote Technologies uses at least 4 email formats:
Antidote Technologies Email FormatsExamplePercentage
First.Last@antidote.meJohn.Doe@antidote.me
70%
First@antidote.meJohn@antidote.me
24%
FLast@antidote.meJDoe@antidote.me
3%
Fir.Last@antidote.meJoh.Doe@antidote.me
3%

Frequently Asked Questions

What is Antidote Technologies's official website and social media links?

Minus sign iconPlus sign icon
Antidote Technologies's official website is antidote.me and has social profiles on LinkedIn and Crunchbase.

How much revenue does Antidote Technologies generate?

Minus sign iconPlus sign icon
As of October 2026, Antidote Technologies's annual revenue is estimated to be $1M - $10M.

What is Antidote Technologies's NAICS code?

Minus sign iconPlus sign icon
Antidote Technologies's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does Antidote Technologies have currently?

Minus sign iconPlus sign icon
As of October 2026, Antidote Technologies has approximately 23 employees across 3 continents, including North America, Europe and Asia. Key team members include President & Founder: D. M., Head Of Communications And Demand Generation: L. C. and Member Board Of Directors: S. W. Explore Antidote Technologies's employee directory with LeadIQ.

What industry does Antidote Technologies belong to?

Minus sign iconPlus sign icon
Antidote Technologies operates in the Research Services industry.

What technology does Antidote Technologies use?

Minus sign iconPlus sign icon
Antidote Technologies's tech stack includes Kubernetes, OneTrust, Salesforce, PostgreSQL, Google Cloud, Atlassian Jira, DocuSign and Elasticsearch.

What is Antidote Technologies's email format?

Minus sign iconPlus sign icon
Antidote Technologies's email format typically follows the pattern of First.Last@antidote.me. Find more Antidote Technologies email formats with LeadIQ.

How much funding has Antidote Technologies raised to date?

Minus sign iconPlus sign icon
As of October 2026, Antidote Technologies has raised $52M in funding. The last funding round occurred on Jun 03, 2021 for $23M.

When was Antidote Technologies founded?

Minus sign iconPlus sign icon
Antidote Technologies was founded in 2010.
Antidote Technologies logo

Antidote Technologies

Research ServicesFlorida, United States11-50 Employees

Antidote Technologies operates in the research services sector, focusing on clinical trial recruitment and patient engagement. It aims to connect patients with researchers to support participation in medical studies, helping to facilitate the clinical research process. The company is based in Miami, Florida, and has a mid-sized team.

Antidote traces its history to 2010, when it launched as TrialReach, and it rebranded to Antidote in 2016. A recent development is the July 2024 integration with Seqster PDM, Inc., a collaboration that combines Seqster's operating system with Antidote's recruitment and engagement capabilities. This places Antidote within the patient-centric digital engagement space of clinical research, serving researchers and sponsors seeking to connect with eligible participants.

Section iconCompany Overview

NAICS Code
5417 - Scientific Research and Development Services
Founded
2010
Employees
11-50

Section iconFunding & Financials

  • $52M

    Antidote Technologies has raised a total of $52M of funding over 6 rounds. Their latest funding round was raised on Jun 03, 2021 in the amount of $23M as a Venture Round.

  • $1M - $10M

    Antidote Technologies's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.